Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-06 Purchase | 2024-12-10 8:46 pm | AN2 Therapeutics Inc. | ANTX | Readnour Robin Shane Director | 60,000 | $1.4451 | $86,708 | 652,573 (Indirect) | View |
| 2024-11-26 Purchase | 2024-11-27 7:07 pm | AN2 Therapeutics Inc. | ANTX | Readnour Robin Shane Director | 75,000 | $1.4091 | $105,685 | 622,573 (Indirect) | View |
| 2024-11-19 Purchase | 2024-11-21 6:00 pm | AN2 Therapeutics Inc. | ANTX | Readnour Robin Shane Director | 200,000 | $1.0656 | $213,128 | 514,788 (Indirect) | View |
| 2024-01-12 Sale | 2024-01-17 5:03 pm | AN2 Therapeutics Inc. | ANTX | Readnour Robin Shane Director | 1,425 | $21.91 | $31,229 | 485,073 (Indirect) | View |
| 2024-01-10 Sale | 2024-01-12 5:08 pm | AN2 Therapeutics Inc. | ANTX | Readnour Robin Shane Director | 3,669 | $21.93 | $80,443 | 485,792 (Indirect) | View |
| 2022-03-29 Purchase | 2022-03-31 8:15 pm | AN2 Therapeutics Inc. | ANTX | Readnour Robin Shane Director | 153,334 | $15 | $2,300,010 | 487,592 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-19 Option Award | 2024-06-21 6:22 pm | N/A 2034-06-18 | AN2 Therapeutics Inc. | ANTX | Readnour Robin Shane Director | 64,503 | $0 | 64,503 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 8:33 pm | N/A 2033-06-06 | AN2 Therapeutics Inc. | ANTX | Readnour Robin Shane Director | 23,742 | $0 | 23,742 (Direct) | View |
| 2022-05-12 Option Award | 2022-05-16 9:25 pm | N/A 2032-05-11 | AN2 Therapeutics Inc. | ANTX | Readnour Robin Shane Director | 20,724 | $0 | 20,724 (Direct) | View |
| 2022-03-29 Conversion | 2022-03-31 8:15 pm | N/A N/A | AN2 Therapeutics Inc. | ANTX | Readnour Robin Shane Director | 751,621 | $0 | 487,592 (Indirect) | View |
Ownership | 2022-03-24 9:21 pm | N/A N/A | AN2 Therapeutics Inc. | ANTX | Readnour Robin Shane Director | 0 | $0 | 751,621 (Indirect) | View |